Literature DB >> 6142947

Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.

P Sneddon, D P Westfall.   

Abstract

The contractile response of the guinea-pig vas deferens to tetanic nerve stimulation was biphasic. The first phase was mimicked by exogenously applied ATP. The second more tonic phase was mimicked by exogenously applied noradrenaline (NA). Intracellular micro-electrodes were used to record the electrical response of the vas deferens to nerve stimulation and to exogenously applied ATP and NA. Local application of ATP (10(-5) to 10(-3)M), by pressure ejection from a micropipette, produced a depolarization similar in magnitude and time course to the excitatory junction potential (e.j.p.). NA produced no such response. Superfusion of the vas deferens with ATP and NA (10(-6) to 10(-4)M) produced a depolarization. The depolarization produced by NA was more gradual than that produced by the same concentration of ATP. The ATP-receptor antagonist ANAPP3 (arylazido aminopropionyl-ATP) preferentially antagonized the first component of the neurogenic contractile response and also antagonized the e.j.p. The alpha-receptor antagonist prazosin preferentially antagonized the second phase of the neurogenic contractile response and enhanced the e.j.p. Similar results were obtained using the irreversible alpha-receptor antagonists phenoxybenzamine and dibenamine. Cocaine (10(-6) and 10(-5)M) enhanced the second phase of the contractile response to nerve stimulation, but reduced the first phase. Lidocaine (10(-5) and 10(-4)M) had no such effect. Cocaine (10(-6) and 10(-5)M) reduced the magnitude of e.j.p.s. at all stimulation frequencies from 1 to 8 Hz. In the presence of the selective alpha 2-receptor antagonist yohimbine (10(-7)M), both phases of the contractile response to nerve stimulation were enhanced to the same degree. This concentration of yohimbine also increased the magnitude of e.j.p.s. In the presence of 10(-7) M-yohimbine, cocaine (10(-6) and 10(-5)M) still enhanced the second phase of the contractile response, but no longer reduced the initial phase of the contraction or e.j.p.s to the same degree. In vas deferens from animals pre-treated with reserpine (2 mg/kg.day), the second phase of the contractile response to nerve stimulation was reduced but neither the first phase of the contraction nor the e.j.p.s was blocked. These results suggest that the first phase of the neurogenic contractile response of the vas deferens and the e.j.p. are mediated by ATP acting on P2-purinoreceptors, whereas NA mediates phase two, via alpha 1-adrenoceptors. The results also suggest that release of ATP and NA is influenced by a negative feed-back mechanism involving presynaptic alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142947      PMCID: PMC1199464          DOI: 10.1113/jphysiol.1984.sp015083

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

Review 1.  Do some nerve cells release more than one transmitter?

Authors:  G Burnstock
Journal:  Neuroscience       Date:  1976-08       Impact factor: 3.590

2.  Evidence against adrenergic motor transmission in the guinea-pig vas deferens.

Authors:  N Ambache; M A Zar
Journal:  J Physiol       Date:  1971-07       Impact factor: 5.182

3.  Nonspecific supersensitivity of the guinea-pig vas deferens produced by decentralization and reserpine treatment.

Authors:  D P Westfall
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

4.  Chemical and histochemical studies on the sympathetic innervation of the vas deferens and seminal vesicle of the guinea pig.

Authors:  A R Wakade; S M Kirpekar
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

5.  Morphological and biochemical changes in supersensitive smooth muscle.

Authors:  D P Westfall; T J Lee; R E Stitzel
Journal:  Fed Proc       Date:  1975-09

6.  Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle.

Authors:  G D Hirst; T O Neild
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

7.  Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus.

Authors:  J C McGrath
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

8.  The inhibition of noradrenaline uptake by drugs.

Authors:  L L Iversen
Journal:  Adv Drug Res       Date:  1965

9.  The use of aryl azido ATP analogs as photoaffinity labels for myosin ATPase.

Authors:  S J Jeng; R J Guillory
Journal:  J Supramol Struct       Date:  1975

10.  Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.

Authors:  N Ambache; L P Dunk; J Verney; M A Zar
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

View more
  121 in total

1.  Quantal and non-quantal current and potential fields around individual sympathetic varicosities on release of ATP.

Authors:  M R Bennett; L Farnell; W G Gibson; Y Q Lin; D H Blair
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: commentary on Jackson and Cunnane.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 3.  Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives.

Authors:  V M Jackson; T C Cunnane
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  ATP mediates excitatory synaptic transmission in mammalian neurones.

Authors:  E M Silinsky; V Gerzanich; S M Vanner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

5.  The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.

Authors:  B Driessen; I von Kügelgen; R Bültmann; D B Elrick; T C Cunnane; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery.

Authors:  I von Kügelgen; K Starke
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

7.  Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

8.  Comparison between sympathetic adrenergic and purinergic transmission in the dog mesenteric artery.

Authors:  I Muramatsu; T Ohmura; M Oshita
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

9.  Electrophysiological analysis of the nature of adrenoceptors in the rat basilar artery during development.

Authors:  N G Byrne; G D Hirst; W A Large
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

10.  Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.

Authors:  P E Hicks; S Z Langer; A D Macrae
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.